TY - JOUR
T1 - Quality of life, body mass index, and physical activity among uterine cancer patients
AU - Lin, Lilie L.
AU - Brown, Justin C.
AU - Segal, Saya
AU - Schmitz, Kathryn H.
PY - 2014/7
Y1 - 2014/7
N2 - Objective: The purpose of this study was to assess the independent and joint effects of body mass index (BMI) and physical activity (PA) on overall quality of life (QoL) in survivors of uterine cancer. Methods: We conducted a survey among uterine cancer patients who received curative therapy at the University of Pennsylvania between 2006 and 2010. Surveys assessed the weight, height, PA (college alumnus survey), and QoL (Functional Assessment of Cancer TherapyYGynecologic Oncology Group). Results: The response rate to the survey was 43%. Among 213 patients, the mean (SD) BMI was 31.1 (8.9) kg/m2, and 48% reported greater than or equal to 150 minIwkj1 of PA. Higher BMI was independently associated with poorer overall QoL (P = 0.050), including physical (P = 0.002) and functional well-being (P = 0.008). Higher minIwkj1 of PAwas not independently associated with any QoL outcome. However, among patients who engaged in greater than or equal to 150 minIwkj1 of PA, the negative association between BMI and overall QoL was attenuated (P = 0.558), whereas among patients who engaged in less than 150 minIwkj1 of PA, the negative association between BMI and overall QoL persisted (P = 0.025). Among patients who engaged in greater than or equal to 150 minIwkj1 of PA, the negative association between BMI and physical and functional well-being was attenuated (P = 0.765 and P = 0.284), whereas among patients who engaged in less than 150 minIwkj1 of PA, the negative association between BMI and physical and functional well-being persisted (P < 0.001 and P = 0.010), respectively. Conclusions: Body mass index is associated with poorer QoL among uterine cancer patients. The findings from this cross-sectional study are consistent with the hypothesis that endometrial cancer survivors who are able to perform 150 min/wk of PA may be protected from the negative effects of BMI on QoL.
AB - Objective: The purpose of this study was to assess the independent and joint effects of body mass index (BMI) and physical activity (PA) on overall quality of life (QoL) in survivors of uterine cancer. Methods: We conducted a survey among uterine cancer patients who received curative therapy at the University of Pennsylvania between 2006 and 2010. Surveys assessed the weight, height, PA (college alumnus survey), and QoL (Functional Assessment of Cancer TherapyYGynecologic Oncology Group). Results: The response rate to the survey was 43%. Among 213 patients, the mean (SD) BMI was 31.1 (8.9) kg/m2, and 48% reported greater than or equal to 150 minIwkj1 of PA. Higher BMI was independently associated with poorer overall QoL (P = 0.050), including physical (P = 0.002) and functional well-being (P = 0.008). Higher minIwkj1 of PAwas not independently associated with any QoL outcome. However, among patients who engaged in greater than or equal to 150 minIwkj1 of PA, the negative association between BMI and overall QoL was attenuated (P = 0.558), whereas among patients who engaged in less than 150 minIwkj1 of PA, the negative association between BMI and overall QoL persisted (P = 0.025). Among patients who engaged in greater than or equal to 150 minIwkj1 of PA, the negative association between BMI and physical and functional well-being was attenuated (P = 0.765 and P = 0.284), whereas among patients who engaged in less than 150 minIwkj1 of PA, the negative association between BMI and physical and functional well-being persisted (P < 0.001 and P = 0.010), respectively. Conclusions: Body mass index is associated with poorer QoL among uterine cancer patients. The findings from this cross-sectional study are consistent with the hypothesis that endometrial cancer survivors who are able to perform 150 min/wk of PA may be protected from the negative effects of BMI on QoL.
UR - http://www.scopus.com/inward/record.url?scp=84904177480&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84904177480&partnerID=8YFLogxK
U2 - 10.1097/IGC.0000000000000166
DO - 10.1097/IGC.0000000000000166
M3 - Article
C2 - 24927246
AN - SCOPUS:84904177480
SN - 1048-891X
VL - 24
SP - 1027
EP - 1032
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
IS - 6
ER -